A Senate committee recently moved forward with a nominee for a crucial health department watchdog role, sparking debates about independence and partisanship. The nominee, Thomas March Bell, is known for his strong support of President Donald Trump and his extensive history working with Republican lawmakers. This has raised concerns about his ability to remain imparti...
A recent standoff between Bon Secours, a major healthcare provider in the Upstate region, and Humana, a significant insurance company, has finally been resolved. This agreement, effective from January 1st, ensures that 16, 245 patients will continue to receive coverage for services under Bon Secours. These patients are part of Medicare Advantage and Managed Medicaid ...
Medicare's open enrollment period is here, and it's crucial to understand your options. This period, which runs from October 15 to December 7, is your chance to switch or change your Medicare plan. It's important to note that the deadline is firm, even if it falls on a weekend. During this time, you can switch your Medicare Advantage plan, change your drug plan, or ...
Retirement planning is not just a future concern; it's something that needs attention now. Many people are not putting away enough money to maintain their current lifestyle once they stop working. The numbers are clear: less than half of Americans are on the right path to a secure retirement. Looking at different age groups, older Gen Z workers are leading the way w...
The Trump administration struck a deal with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 drugs. These drugs help with weight loss, diabetes, and other health issues. Starting soon, people will pay about $350 a month for these injectable drugs. This price will drop to $250 over the next two years for those paying without insurance. The deal also includes a d...
A recent deal will allow Medicare to cover weight loss drugs, but it comes with a hefty price tag. The prices for drugs like Ozempic and Wegovy will drop significantly when bought through Medicare and Medicaid. Ozempic will cost $350 per month instead of $1, 000, and Wegovy will be $350 instead of $1, 350. Other drugs will be even cheaper, around $145 per month. This...
Doctors are now using tech to keep an eye on patients' health from afar. This means they can check things like blood pressure without needing an in-person visit. It's not just about convenience, though. This tech might also help more people see their family doctor. A recent study found that clinics using this tech can handle more patients, even those with tricky hea...
Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs for $149 a month. This is a big drop from what they usually charge. ...
Metsera is at the center of a heated battle between two pharmaceutical giants, Pfizer and Novo Nordisk. It all started when Novo Nordisk made a surprising offer to buy Metsera for $6. 5 billion, even though Metsera had already agreed to a smaller deal with Pfizer. This has led to a legal fight, with Pfizer accusing Novo Nordisk of trying to eliminate competition in t...
The cannabis market is buzzing with potential, thanks to some big changes on the horizon. Investors are feeling hopeful, especially with President Trump showing interest in cannabis and hemp products. This could mean new rules and better opportunities for the industry. One company, Verano Holdings, recently shared its earnings. They made $203 million, which is a bit...